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　　Candida albicans (C. albicans) is the primary etiological agent of candidemia. One 
of the mechanisms of its onset involves migration of oral C. albicans to the intestinal 
tract, where it proliferates, damages the mucous membrane, and enters blood vessels. 
The present study aimed to examine the influence of bacteria constituting the intestinal 
flora and changes in immune function on the colonization of C. albicans in the intestinal 
tract using a mouse model of oral candidiasis.
　　ICR mice were subcutaneously injected with 0.2 mg prednisolone and provided 
access to water containing 4 mg/ml tetracycline. The next day, 0.1 mg chlorpromazine 
was injected intramuscularly. Ten minutes later, C. albicans was applied to the oral 
cavity with a swab. Feces were then collected, and C. albicans and bacterial counts were 
determined to derive the microbial count for the intestinal tract. Metagenome analysis 
was also performed to clarify bacterial types present in the feces.
　　Five days after infection, fecal C. albicans counts were significantly high in the 
prednisolone+tetracycline group compared to the untreated group, the prednisolone 
only group, and the tetracycline only group. To examine whether these results could be 
attributed to a reduction in bacterial count in the intestinal flora, we determined the 
fecal bacterial count in the prednisolone+tetracycline group.
　　First, we determined fecal aerobic and anaerobic bacterial counts. Both counts were 
higher in the prednisolone+tetracycline group than the untreated group. These suggest 
that colonization of C. albicans in the intestinal tract is not promoted by the low number 
of bacteria in the intestinal flora. To further assess the underlying mechanism, we 
examined fluctuations in the numbers of various types of bacteria in the intestinal flora 
using metagenome analysis. In the prednisolone+tetracycline group, the proportion of 
Bacteroides increased while that of Lactobacillus decreased, suggesting that a reduction 
in the number of Lactobacillus in the intestinal tract may promote C. albicans coloniza-
tion.
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緒　　　言
　口腔カンジダ症は，口腔常在真菌の Candida 

































































vates T cell immune function, to mice on the colonization of C. albicans in the intestinal 
tract. When the anti-PD-1 antibody was administered one day before infecting mice 
with C. albicans, there was a significant increase in the colonization of C. albicans in the 
intestinal tract. This could potentially be explained by feedback suppression of T cell 
function resulting from hyperactivation of T cell function by the anti-PD-1 antibody.
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Carlsbad, CA, USA)含有RPMI1640培養液 (Sigma, 
St. Louis, MO, USA)５ml中に浮遊させたもの

































































　７． 統 計 処 理
　統計処理は one-way analysis of varianceを用




























　口腔内に C. albicans，Candida glabrata (C. 























それとほぼ同数の C. glabrata及び C. tropicalis
も検出された（図３）。
　この結果から，C. albicansの腸管内への定着













































5日後 15日後 21日後 37日後
C. albicans C. glabrata C. tropicalis
5 15 21 37
図２　C. albicans感染５日後の菌数 
　　　平均値±SDを示す
　　　 * P < 0.01：コントロールに対する有意差, 
　　　# P < 0.01：テトラサイクリン(－)に対する有意差,















































































* P < 0.05, ** P < 0.01：コントロールに対する有意差
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なお，C. albicans以外の Candida spp.でも腸
管内への安定した定着が起こるのかを調べたとこ





















































　　　** P < 0.01：プレドニゾロン(－)に対する有意差, 
　　　## P < 0.01：抗 PD-1 抗体(－)に対する有意差
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Matsudaらも，Lactobacillus gasseri とLactobacillus 
crispatus の培養上清がC. albicans のバイオフィ
ルム形成を抑制するとしている20)。以上のことか
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